Eledivys from what I have read has limitations and not overly expansive with treatment and age - approved or not.
Should PER show promising results the broader application will imo eliminate/reduce Eledivys to a point where PER has so much leverage in negotiation of any partnership moving forward that the Seraptas of the world will not be able to sit back and just watch. All power to PER if they play it right and are strategic with the results. Maybe AF will come into it then.
Fingers are crossed that PER results at a minimum, to replicate previous results. Any advances on previous results and bang - we are on BIG TIME!
***Did take me a bit to type in PER and not ANP***
Eledivys from what I have read has limitations and not overly...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 11000 | 1 |
View Market Depth
| Last trade - 10.19am 06/05/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable